Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards a treatment for genetic prion disease: trials and biomarkers
Sonia M. Vallabh, Eric Vallabh Minikel, Stuart L. Schreiber, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 4, pp. 361-368
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
Péter Hermann, Brian S. Appleby, Jean‐Philippe Brandel, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 3, pp. 235-246
Open Access | Times Cited: 257
The importance of ongoing international surveillance for Creutzfeldt–Jakob disease
Neil Watson, Jean‐Philippe Brandel, Alison Green, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 362-379
Open Access | Times Cited: 137
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
M H Miran Beygi, Fatemeh Oroojalian, Soheil Azizi‐Arani, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 19
Closed Access | Times Cited: 24
Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor
Edwin N. Neumann, Tessa M. Bertozzi, Elaine Wu, et al.
Science (2024) Vol. 384, Iss. 6703
Closed Access | Times Cited: 22
Creutzfeldt–Jakob disease and other prion diseases
Inga Zerr, Anna Ladogana, Simon Mead, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 21
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
Eric Vallabh Minikel, Hien Zhao, Jason Le, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 19, pp. 10615-10631
Open Access | Times Cited: 98
A single-cell map of antisense oligonucleotide activity in the brain
Meredith A Mortberg, Juliana E Gentile, Naeem Nadaf, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 14, pp. 7109-7124
Open Access | Times Cited: 28
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
Andrew G.B. Thompson, Prodromos Anastasiadis, Ronald Druyeh, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5955-5966
Open Access | Times Cited: 42
Genetic aspects of human prion diseases
Brian S. Appleby, Shashirekha Shetty, Mohamed Elkasaby
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 32
New implications for prion diseases therapy and prophylaxis
Fangzhou Liu, Wenqi Lü, Ling Liu
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
Sonia M. Vallabh, Eric Vallabh Minikel, Victoria J. Williams, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 46
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease
Samir Abu‐Rumeileh, Simone Baiardi, Anna Ladogana, et al.
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 11, pp. 1181-1188
Closed Access | Times Cited: 45
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases
Giovanni Palermo, Sonia Mazzucchi, Alessandra Della Vecchia, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 11, pp. 4667-4691
Closed Access | Times Cited: 43
Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases
Akshay Bandiwadekar, Jobin Jose, Maryam Khayatkashani, et al.
Journal of Molecular Neuroscience (2021) Vol. 72, Iss. 3, pp. 653-676
Closed Access | Times Cited: 35
Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials
Meredith A Mortberg, Sonia M. Vallabh, Eric Vallabh Minikel
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Genetic counseling for prion disease: Updates and best practices
Jill Goldman, Sonia M. Vallabh
Genetics in Medicine (2022) Vol. 24, Iss. 10, pp. 1993-2003
Closed Access | Times Cited: 25
Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS
Meredith A Mortberg, Hien Zhao, Andrew G. Reidenbach, et al.
JCI Insight (2022) Vol. 7, Iss. 6
Open Access | Times Cited: 21
Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion
Sonia M. Vallabh, Meredith A Mortberg, Shona W. Allen, et al.
Neurology (2024) Vol. 103, Iss. 2
Open Access | Times Cited: 4
Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease
Steffen Halbgebauer, Samir Abu‐Rumeileh, Patrick Oeckl, et al.
Neurology (2022) Vol. 98, Iss. 14
Closed Access | Times Cited: 18
Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease
Vignesh Sundararajan, Ulrike Burk, Karolina Bajdak-Rusinek
Biomolecules (2022) Vol. 12, Iss. 6, pp. 781-781
Open Access | Times Cited: 17
Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease
Sonia M. Vallabh, Dan Zou, Rose Pitstick, et al.
Journal of Virology (2023) Vol. 97, Iss. 2
Open Access | Times Cited: 10
Chaperone-mediated autophagy in neurodegenerative diseases: mechanisms and therapy
Yi Liu, Ming Tan, Meng‐Shan Tan
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2173-2190
Closed Access | Times Cited: 10
Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease
Anuradha Sharma, Poonam Piplani
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 13, pp. 1260-1276
Closed Access | Times Cited: 9
Multimodal small-molecule screening for human prion protein binders
Andrew G. Reidenbach, Michael F. Mesleh, Dominick Casalena, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 39, pp. 13516-13531
Open Access | Times Cited: 24
Therapeutic advances in neuroinfectious diseases
Rumyar Ardakani, Lucy Jia, Elizabeth Matthews, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top